Development of Drug Delivery System for Intrathecal Administration and Its Therapeutic Effect on Cerebral Vasospasm and Ischemia

DOI Web Site Web Site PubMed 1 Citations 51 References
  • ISHIDA Tatsuhiro
    Department of Pharmacokinetics and Biopharmaceutics, The University of Tokushima

Bibliographic Information

Other Title
  • 脳脊髄腔投与可能なDDSの開発とその脳保護効果の検討
  • ノウ セキズイ クウ トウヨ カノウ ナ DDS ノ カイハツ ト ソノ ノウ ホゴ コウカ ノ ケントウ

Search this article

Abstract

  To date, the pharmacologic approach to cerebral vasospasm and ischemia has been hampered in part by an inability to attain sufficiently high concentrations of drugs in the cerebrospinal fluid (CSF). To overcome this limitation of current drug therapy, we have developed a sustained-release preparation of the protein kinase inhibitor fasudil. Experimental cerebral vasospasm in rats and dogs was induced by double injection of autologous arterial blood into the cisterna magna. Focal cerebral ischemia in rats was induced by middle cerebral artery occlusion using an intraluminal suture technique. A single intrathecal injection of liposomal fasudil can maintain a therapeutic the drug concentration in the CSF due to the sustained-release property of liposomes, significantly decreasing intarct size of acute ischemia and decreasing vasoconstriction of the basilar artery in cerebral vasospasm. This novel approach for the treatment of cerebral vasospasm and ischemia may have significant potential for use in the clinical setting.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 124 (8), 541-547, 2004-08-01

    The Pharmaceutical Society of Japan

Citations (1)*help

See more

References(51)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top